Guerbet results benefit from Mallinckrodt deal

Contrast agent manufacturer Guerbet showed a sharp upturn in revenues for 2016,...

Read more on AuntMinnieEurope.com

Related Reading:

Guerbet concurs with gadolinium recommendations

Guerbet, Methapharm sign Canadian deal

Guerbet reaches milestone

Guerbet sees first-half revenues edge down

Guerbet makes changes to board of directors

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nhsKUy
via IFTTT